Effect of Leech Therapy and Polyherbal Unani Formulations in the Management of Primary Varicose Veins
Phase 2
- Conditions
- Health Condition 1: I832- Varicose veins of lower extremities with both ulcer and inflammation
- Registration Number
- CTRI/2024/03/064489
- Lead Sponsor
- Hakim Syed Ziaul Hasan Government Unani Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients clinically diagnosed with primary varicose veins
2. Patients willing to give written informed consent and follow the
protocol.
Exclusion Criteria
1. Patients below 20 years and above 60 years of age.
2. Pregnant and lactating women.
3. Patients who fail to follow up.
4. Patients of diabetes and severe hypertension.
5. Patient who are taking Anti-coagulant therapy
6. Patients of secondary varicose veins.
7. Patients of Deep Venous Thrombosis (DVT).
8. Patients of coagulopathy.
9. Patients of severe systemic diseases.
10. Patients unwilling to give written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Revised Venous Clinical Severity Score (VCSS) <br/ ><br>2.Standard Color DopplerTimepoint: 1. Revised Venous Clinical Severity Score (VCSS) on 0, 7th, <br/ ><br>14th, 21st, 28th, 35th and 42nd day <br/ ><br>2.Standard Color Doppler on 0 and 42nd day.
- Secondary Outcome Measures
Name Time Method To measure the girth below knee and above ankleTimepoint: On 0 and 42nd day